Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Clinical trial NCT03906071 · COMPLETED
Trial details
- NCT number
- NCT03906071
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2023-03-20
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.